Earnings Call · Q2 FY2024·2024-08-16

Q2 24EPS +40.30%·Rev n/aQ1 24EPS -100.00%*·Rev n/aQ4 23EPS -100.00%*·Rev n/aQ3 23EPS 0.00%·Rev n/a⚠ consensus missing

LENZ Therapeutics, Inc. LENZ

Dan Chevallard — Chief Financial Officer

Eef Schimmelpennink — President and Chief Executive Officer

Shawn Olsson — Commercial Leader

−3.8%1d on move date−5.5% vs SPY3d−3.4%5d−4.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LENZ calls or request research access.

More LENZ calls Browse calls Request research access